You are here: Industry Insights > profit

News List

Regeneron's Sanofi deal finally turns a profit, thanks to Dupixent fiercepharma
August 07, 2019
More than 10 years after Sanofi and Regeneron joined forces in a high-profile antibody drug partnership, the tie-up has recorded its first-ever profits—no thanks to the PCSK9 laggard Praluent, but with big bouquets for hard-driving Dupixent.
Mylan investors are fed up with management—and for good reason, analysts say fiercepharma
May 12, 2019
The company's paying its chairman for not using its plane, for instance, and it's been shelling out to a company run by his brothers and son for decades.
AARP ads tackle Big Pharma lobbying fiercepharma
November 27, 2018
AARP is taking on Big Pharma with a new campaign to convince lawmakers to resist drug industry lobbying. In new TV ads begun last week, the advocate for older Americans urges legislators to “protect seniors, not drug company profits.”
Sun closing New Jersey plant, laying off nearly 100, to cut costs in 'competitive' U.S. market fiercepharma
November 27, 2018
With competition in the U.S. generics market mashing down margins, some drugmakers have been selling or closing plants to cut costs. India's Sun Pharma has joined that trend and will close a plant in New Jersey, costing nearly 100 workers their jobs.
Sun Pharma posts net profit of ₹ 996 crores at Q2FY19 expressbpd
November 15, 2018
In H1FY19,the company’s sales / income from operations was at ₹ 13,985 crores
Natco Pharma posts over two-fold jump in Q2 PAT to ₹ 181.6 crore expressbpd
November 06, 2018
The company had posted a consolidated profit after tax of ₹ 84.4 crore in the same quarter
Johnson & Johnson lifts annual guidance as third-quarter sales, profit top estimates biospectrumasia
October 17, 2018
Top Story AL-8176 Darzalex Imbruvica Invega Sustenna Opsumit Prezista Remicade Simponi Stelara Tracleer Trevicta Uptravi Xarelto Xeplion Zytiga J&J Corporate Affairs
RPG Life Sciences posts reduction in profit in Q1FY18 expressbpd
August 07, 2017
Domestic formulations sales impacted due to GST transition
Mylan's first-quarter profit rises, but sales increase misses estimates firstwordpharma
May 11, 2017
Mylan announced Wednesday that first-quarter profit reached $66.4 million, up from $13.9 million in the year-ago period. Meanwhile, sales jumped 24 percent year-over-year to $2.7 billion, although the figure fell short of analyst estimates of $2.8 billion
Hester Biosciences net profit up by 29 per cent in Q4 FY17 financialexpress
May 09, 2017
The company has recommended final dividend of Rs 2.30 per share

Previous page 1 2 3 4 Next page